It was recently suggested that supplying the brain with new neurons could counteract Alzheimer's disease. This provocative idea requires further testing in experimental models where the molecular basis of disease-induced neuronal regeneration could be investigated. We previously found that zebrafish stimulates neural stem cell (NSC) plasticity and neurogenesis in Alzheimer's disease and could help to understand the mechanisms to be harnessed for develop new neurons in diseased mammalian brains. Here, by performing singlecell transcriptomics, we found that Amyloid toxicity-induced Interleukin-4 induces NSC proliferation and neurogenesis by suppressing the tryptophan metabolism and reducing the production of Serotonin. NSC proliferation was suppressed by Serotonin via downregulation of BDNF-expression in Serotoninresponsive periventricular neurons. BDNF enhances NSC plasticity and neurogenesis via NGFRA/NFkB signaling in zebrafish but not in rodents. Collectively, our results suggest a complex neuron-glia interaction that regulates regenerative neurogenesis after Alzheimer's disease conditions in zebrafish.
Introduction
Alzheimer's disease (AD) entails versatile pathological changes such as synaptic degeneration, neuronal death, chronic inflammation, impaired vasculature function and reduced plasticity of neural stem cells (De Strooper and Karran, 2016; Moreno-Jimenez et al., 2019; Selkoe and Hardy, 2016) . The cognitive decline that is observed in AD patients and experimental animal models is mainly caused by the reduced neural network integrity (Arendt, 2009) . The efforts to rescue the cognitive decline and neuronal death traditionally largely focused on the neuronal compartment and aimed at preventing the death of the neurons while this has not yielded in desired success in clinics (Cummings et al., 2016; Mehta et al., 2017 ). An alternative approach was suggested to be to complement the treatment in neuronal compartments with increasing the production of new neurons to provide resilience and strength to the diseased circuitry (Choi et al., 2018; Moreno-Jimenez et al., 2019; Mu and Gage, 2011; Tincer et al., 2016) . Yet, neurogenesis in human brains is quite controversial (Arellano et al., 2018; Cipriani et al., 2018; Dennis et al., 2016; Duque and Spector, 2019; Sorrells et al., 2018) . Although many reports documented the presence of adult neurogenesis in human brains (Boldrini et al., 2018; Ernst et al., 2014; Kempermann et al., 2018; Magnusson and Frisen, 2016; Moreno-Jimenez et al., 2019; Spalding et al., 2013) , and several studies demonstrated that boosting the neurogenesis might be a viable option for alleviating the cognitive decline (Casse et al., 2018; Choi et al., 2018; Martinez-Canabal, 2014; Papadimitriou et al., 2018; Rodriguez and Verkhratsky, 2011) , the potential benefits of neurogenic outcome in AD conditions requires further investigation and critical testing. Additionally, in AD conditions, mammalian NSCs reduce the proliferative ability dramatically, and for neurogenesis to become a viable option for treatment of neurological disorders, mammalian NSCs must become plastic first. Therefore, examining how NSCs could be made proliferative and neurogenic during the course of AD could provide important clinical ramifications towards the treatment of this disease (Kizil and Bhattarai, 2018a) ; however, little is known about the mechanisms by which neural stem cells would enhance their proliferative response (Dong et al., 2019; Kempermann et al., 2018; Morrens et al., 2012) . Recently, we established a zebrafish model, which can recapitulate the symptoms of AD in humans such as neuronal death, synaptic degeneration, chronic inflammation and cognitive decline (Bhattarai et al., 2017a; Bhattarai et al., 2016) . Interestingly, in contrast to humans, zebrafish brain could enhance NSC proliferation and neurogenesis through a previously unidentified neuro-immune regulation involving Interleukin-4 (IL4). IL4 secreted by dying neurons and activated microglia, which in turn activated NSC proliferation . We also found that IL4 could revert the pathological effects on NSC in an in vitro 3D reductionist model of AD (Papadimitriou et al., 2018) . Yet, the mechanisms by which IL4 regulates NSC proliferation and neurogenesis after Amyloid toxicity remained unknown. In this manuscript, using single cell sequencing, we identified a previously undocumented IL4-dependent mechanism that regulates NSC plasticity in adult zebrafish brain, where IL4 regulates production of Serotonin, which suppresses production of the brain-derived neurotrophic factor (BDNF) in periventricular neurons juxtaposing the NSCs. We found that BDNF is required to activate NSC plasticity, proliferation of NSCs, and neurogenesis through its receptor nerve growth factor receptor A (NGFRA), the blockage of which reduces NSC proliferation. Overall, our results identify a mechanism by which IL4 regulates NSC plasticity through Serotonin-dependent expression of BDNF in neurons in zebrafish brain, and demonstrate functional heterogeneity of NSCs based on receptor expression. Our results will provide a conceptual basis for neuroimmune regulation of NSCs, neuronal control of NSC proliferation, and differential response of NSC subtypes to various signals in zebrafish. Such understanding could be instrumental in the efforts to develop novel therapies for Alzheimer's disease through increased neurogenesis.
Results
To determine the effects of Interleukin-4 (IL4) on neural stem cell (NSC) plasticity in adult zebrafish brain, we administered IL4 through cerebroventricular microinjection, dissected the telencephalon and performed a whole transcriptome profiling in control and IL4-injected brains ( Figure 1A , Figure S1 ). By comparing the gene expression profiles, we found that IL4 administration increased the expression of 285 genes while downregulated 1435 genes ( Figure 1B , Dataset S1). To determine the pathways affected by IL4, we performed KEGG analyses and observed that one of the significantly regulated pathways was Tryptophan metabolism ( Figure 1C , Figure S1 ). Specifically, we observed that the enzymes generating Serotonin from Tryptophan were downregulated ( Figure 1D , Dataset S2), suggesting that IL4 might reduce the production of Serotonin (5-HT). To test whether Amyloid-beta42 (Aβ42, which induces IL4 expression ) and ectopic IL4 would reduce the availability of 5-HT in adult zebrafish brain, we performed immunohistochemistry for 5-HT ( Figure 1E ) and observed that Aβ42 and IL4 significantly reduces the 5-HT immunoreactivity in adult zebrafish telencephalon ( Figure 1F ) but the cell bodies at more caudal regions still existed ( Figure S2A -C), suggesting that Aβ42/IL4 suppresses Serotonin production rather than the innervation. Additionally, the effects of IL4 is specific to Serotonergic system, as in our deep sequencing analyses we did not observe changes in KEGG analyses in other neurotransmitter pathways such as dopamine, histamine or noradrenalin (Dataset S2).
Since Aβ42/IL4 enhances neural stem cell (NSC) proliferation in adult zebrafish brain (Bhattarai et al., 2017a; Bhattarai et al., 2016; Bhattarai et al., 2017b; Kizil, 2018; Kizil and Bhattarai, 2018b) and they downregulate 5-HT ( Figure 1E ,F), we hypothesized that 5-HT could be negatively affecting NSC plasticity. To test this, we injected 5-HT into adult zebrafish brain and analyzed the proliferation of NSCs (S100b/PCNA double positive cells) (Figure 2A -C). We observed a significant reduction of NSC proliferation after 5-HT injection ( Figure 2C ). This reduction has implications in neurogenesis from NSCs, as the analysis of BrdUlabeled newborn neurons at 14 days after injection of PBS ( Figure 2D ) or 5-HT ( Figure 2E ) showed that 5-HT reduces the neurogenic outcome ( Figure 2F ). To verify our results, we used a transgenic reporter line that marks NSCs with GFP driven under the her4.1 promoter and injected Aβ42, IL4 or 5-HT followed by immunohistochemisty for GFP and PCNA ( Figure 2G ). Consistent with our previous results, Aβ42/IL4 injection increased NSC proliferation, while 5-HT reduced the number of proliferating progenitors ( Figure 2H ), indicating that 5-HT has a negative impact on NSC plasticity in zebrafish telencephalon. To further test whether the negative effects of 5-HT would be reversed by Aβ42 or IL4, we co-injected 5-HT with Aβ42 and IL4, and observed that the reduction in NSC proliferation by 5-HT can be abrogated by Aβ42 or IL4 ( Figure S2D -H) indicating that 5-HT signaling acts antagonistically to IL4 in NSCs.
Our previous results indicated that a subset of NSCs express IL4 receptor and can therefore be directly regulated by IL4 Cosacak et al., 2019) . Therefore, we aimed to investigate if 5-HT would affect the same subset of NSCs or whether it affects a distinct population. To determine whether or not 5-HT has a direct effect on NSCs, we determined the spatial organization of NSCs (her4.1:GFP, Figure 2I ,J) and 5-HT innervation ( Figure 2I ,K). We observed that NSCs are located apically and are separated by periventricular zone (PVZ) neurons before the proximal front of the Serotonergic innervation in the parenchyma ( Figure 2I ), suggesting that the effect of 5-HT on NSCs could be indirect. If this hypothesis would be true, NSCs would not express 5-HT receptors. To determine which cells expressed 5-HT receptors, we performed in situ hybridization for 5-HT receptors (htr genes) and observed that among 7 serotonin receptor genes and in total 21 isoforms of those genes (Dataset S2), only htr1a and htr1d gave in situ hybridization signals in adult zebrafish brain ( Figure 2L -M'), and serotonin receptor genes are not expressed in the progenitor cells ( Figure S2I ), supporting previous findings (Norton et al., 2008) . htr1a was expressed only in ventral regions ( Figure 2L ,L') while htr1d was present in periventricular region immediately adjacent to the ventricular zone containing the NSCs that span the medial and dorsal regions of the telencephalon ( Figure  2M ,M'). These findings suggested that the effect of 5-HT on NSCs is not direct, and it could be mediated through periventricular neurons expressing htr1d ( Figure 2N ). If 5-HT would act on periventricular neurons, 5-HT would activate its downstream effector pERK (Huang and Reichardt, 2003) in periventricular regions. Indeed, we found that compared to controls where nuclear pERK is in few cells at the PVZ ( Figure 2O ), 5-HT injection increases the number of pERK+ nuclei only in the PVZ region ( Figure 2N ). Quantification of pERK-positive nuclei also confirmed that 5-HT increases pERK-positive nuclei on the contrary to Aβ42/IL4 ( Figure 2O ), indicating that 5-HT directly affects periventricular neurons but not the NSCs ( Figure 2N ).
To determine the mechanistic link between 5-HT and NSC plasticity through hrt1+ cells ( Figure 2P ), we performed single cell transciptomics in control and 5-HT-treated adult zebrafish telencephalon by unbiased clustering, determination of cell types and differential gene expression analyses using the methodology we have recently developed (Cosacak et al., 2019; Cosacak et al., 2018) (FigureS3A; Dataset S3 ). After quality control analyses ( Figure S3B ), we obtained tSNE clusters, which dissolve into four major cell types: neurons (eno2, gap43, map1aa, sypb-positive), glia (gfap, her4.1, msi1, s100b-positive); oligodendrocytes (aplnrb, olig2-positive) and immune cells (pfn, lcp1-positive) ( Figure S3C -E). Heat maps reveal marker genes expressed predominantly in those cells ( Figure S3C ) To determine the cells that are responsive to 5-HT, we plotted the cells expressing htr1 and observed that htr1 expression was confined to neurons ( Figure S3F ). This expression pattern was consistent with in situ hybridization results of htr1d ( Figure 2M ) and was distinct than il4r.1 expressing cells that were exclusively glia and immune cells and Figure S3F ).
To determine the mechanism by which 5-HT-responsive cells affect glia proliferation, we devised an analysis pipeline where we dissected the htr1+ cells from the rest and performed differential expression analysis between control and 5-HT-treated brains ( Figure 3A ; Figure S3G ). We found that 349 genes changed their expression levels in htr1+ cells after 5-HT treatment ( Figure 3B , Dataset S4). We hypothesized that a possible regulation between htr1+ neurons and NSCs could be through a paracrine ligand-receptor crosstalk. We found that in htr1+ cells, 29 ligands change their expression levels ( Figure 3C ), five of which also change their expression reciprocally after 5-HT or IL4 treatment ( Figure 3D , and data from (Cosacak et al., 2019) ). The highest fold change was observed for bdnf, which is enhanced by IL4 and downregulated by 5-HT ( Figure 3D ).
We found that bdnf was predominantly expressed in neuronal clusters (90% in neurons and 8% in glial cells; Figure3E; FigureS3H), while its receptor ntrk2 (Abbate et al., 2014; Lucini et al., 2018) was expressed mainly in neurons (68% neuronal and 28% glia; Figure3E; FigureS3H), while another BDNF receptor ngfra (Abbate et al., 2014; Cacialli et al., 2016; Lucini et al., 2018) was mostly glial (93% in glia and 5% in neurons; Figure3E; FigureS3H). Therefore, we hypothesized that 5-HT dependent regulation of bdnf expression might signal to the glial cells through ntrk2 and ngfra in adult zebrafish brain.
To further investigate if BDNF signaling through Ntrk2 or Ngfra would affect NSCs, we used an in silico interaction map analyses we recently developed (Cosacak et al., 2019) . According to this analyses, if BDNF would have a potential interaction between neuronal and glial (progenitor) clusters, we would see an in silico interaction between these cells. Alternatively, if ntrk2 or ngfra could constitute a crosstalk between neuronal and glial clusters, we would be able to see an interaction (see (Cosacak et al., 2019) for details of interaction mapping). For interaction analyses, we used the spatial organization map of adult zebrafish NSCs in the telencephalon ( Figure 3F ), distinguished the cell types based on our previous findings ( (Cosacak et al., 2019) ) by using machine learning algorithms, and compared the three treatments with controls (IL4 vs. control, Amyloid vs. control, and 5-HT vs. control) ( Figure 3G ,H; Figure S4A ). For mapping, we used the following three criteria: (1) we took either the bdnf as a starting point (i.e.: the cells expressing bdnf are matched with the cells expressing any bdnf receptor, or the bdnf receptors ntrk2 and ngfra were taken as starting points (i.e.: only ntrk2 or ngfra-expressing cells were matched with cells expressing any ligand for those receptors (Figure3H for ngfra and Figure S4A for ntrk2)); (2) charted the potential interactions as arrows starting from bdnf-expressing clusters to bdnf receptor-expressing clusters ( Figure 3G ) or to bdnf receptorexpressing clusters from clusters expressing their ligands (Figure3H), and (3) depending on the change of the interaction after any treatment, we color-coded the interactions (black arrows indicate interactions that are unchanged by the treatment, cyan arrows indicate the interactions that are lost after treatment, and magenta arrows indicate interactions that emerged after a particular treatment). After these analyses, we found that especially two clusters of progenitor cells (PC0 and PC2, which are located to dorsal and medial region of the telencephalon ( Figure 3F ) and (Cosacak et al., 2019) ) were among the clusters that had the highest number of arrows pointing towards them (Figure3G). Interestingly, the majority of the potential interactions were newly generated after Amyloid or IL4 treatment while those interactions are mainly lost after 5-HT treatment ( Figure 3G , green circles), suggesting that the regulation of progenitor cells (neural stem cells) by bdnf could be promoted by Amyloid or IL4 treatment and suppressed by 5-HT, which is consistent with our hypothesis. Additionally, to support our findings, we performed independent mapping analyses of bdnf receptors ntrk2 and ngfra. We constructed interaction maps for these receptors and found that ngfra might be the main receptor for bdnf signaling in adult zebrafish telencephalon as two NSC clusters (PC0 and PC2) were at the center of the interaction maps with many potential interactions ( Figure 3H ) while ntrk2 interaction map provided only small number of interactions to another glial cluster (PC7) ( Figure S4A ). We observed that IL4 activates many interaction routes to NSC clusters while 5-HT almost diminishes all the interactions between NSCs and other cells ( Figure 3H ). These in silico analyses suggest that IL4 promotes the interactions between neurons and NSCs while 5-HT rather suppresses such interactions.
To verify our in silico analyses for interaction mapping on single cell transcriptomics data and to investigate the changes in the expression of bdnf, we performed in situ hybridization on control ( Figure 4A ), 5-HT-injected ( Figure  4B ) and IL4-injected brains ( Figure 4C ). The expression of bdnf in control brains was in periventricular zone (PVZ) proximal to the NSCs, which confirmed our single cell transcriptomics data. The expression of bdnf was almost abolished by 5-HT injection ( Figure 4B ) while it is enhanced by IL4 ( Figure 4C ), suggesting that 5-HT suppresses NSC plasticity through reducing the bdnf signaling.
Given that 5-HT suppresses bdnf expression and NSC proliferation while IL4 enhances bdnf expression and NSC proliferation, we hypothesized that bdnf would also enhance NSC plasticity by increasing cell proliferation. To test this, we injected BDNF into control zebrafish brains ( Figure 4D -E) and observed that BDNF indeed increases the number of proliferating NSCs ( Figure 4E ). The enhanced proliferation of NSCs by BDNF is also translated into increased neurogenesis as BDNF-injected brains produce more neurons compared to control-injected zebrafish brains (Figure4F, G), indicating that BDNF enhances NSC plasticity in adult zebrafish brain.
If BDNF would act directly on NSCs, its receptor must have been present in the target cells. Therefore, we performed in situ hybridization for ntrk2 and ngfra in adult zebrafish brains. We observed that ntrk2 mRNA is expressed mainly in periventricular region of the telencephalon ( Figure 4H and Figure S4B ), which is supported by immunohistochemical staining for NTRK2 protein ( Figure S4C ). On the contrary, ngfra is expressed mainly in ventricular zone where NSCs reside ( Figure 4I , Figure S4 ). These findings are perfectly matching with our single cell transcriptomics data ( Figure 3E , Figure S3H ), and suggest that ngfra is the primary receptor for bdnf in NSCs and ntrk2 is the primary receptor in neurons. To test this hypothesis, we injected BDNF into adult zebrafish brain and determined the downstream effectors of NTRK2 and NGFRA signaling pathways.
To determine the cells responding to BDNF/NTRK2 signaling, we detected the downstream effector pAkt (Huang and Reichardt, 2003) and observed that after BDNF injection, pAkt is almost exclusively present in periventricular cells and parenchymal neurons (few speckles in ventricular region constitute less than 0.1% of the pAkt signal when compared to the intensity and number of cells outside the ventricular region) ( Figure S4D ,E). On the contrary, compared to control-injected brains, BDNF injection increased the activity of the NFkB reporter (Kanther et al., 2011) , which is the downstream effector of NGFR signaling (Hamanoue et al., 1999) in the ventricular region where NSCs reside ( Figure 4J -M). Additionally, consistent with the results of BDNF injections, Aβ42 or IL4 injections increased but 5-HT injection reduced the NFkB signaling and the number of NFkB-positive proliferating NSCs (S100b/PCNA/NFkB:GFP-triple positive cells; Figure S4G ,H). These results indicate that NGFR-mediated intracellular signaling is the primary route for the 5-HT-dependent BDNF activity on NSCs in adult zebrafish brain.
If our hypothesis were true and BDNF would regulate NSC proliferation through NGFRA and NFkB signaling, knocking-down ngfra receptor after BDNF injection would suppress the increase in NSC proliferation by BDNF as well as the increase in NFkB signaling. To test this hypothesis, we knocked down ngfra by using morpholino oligonucleotides and determined the extent of proliferating NSCs ( Figure 4N-N5 ). Compared to control brains, BDNF increased the NSC proliferation; control morpholino did not alter this increase while ngfra morpholino diminished the increased NSC proliferation upon BDNF injection (Figure4O).
Since BDNF/NGFRA signaling is affected by IL4 that also acts directly on NSCs through IL4R , we hypothesized that the effect of IL4 on NSCs could be mediated through IL4R (directly by IL4/IL4R interaction) and NGFR (through 5-HT/BDNF/NGFRA/NFkB axis) distinctly, and IL4R-positive and NGFRA-positive glia would constitute two functional subtypes of NSCs. To determine whether IL4R-positive and NGFRA-positive NSCs are distinct subtypes of NSCs in adult zebrafish brain, we plotted both cell populations on the same tSNE plot ( Figure 4P ). We observed that only 3,2% of ngfra-positive NSCs were also il4r1-positive (24,5% are only il4r-positive and 72.3% are only ngfrapositive), indicating that these two populations are likely to represent two functional subtypes of NSCs. We further hypothesized that if ngfra-positive and il4r-positive NSCs would constitute different subtypes, their response to particular treatments would also lead to distinct differential gene expression profiles. To address this question, we determined the overlap between differentially expressed genes in il4r-positive and ngfra-positive NSCs ( Figure  4Q ). We determined that after IL4 treatment 423 and 895 genes are differentially expressed in il4r+ (Dataset S5) and ngfra+ (Dataset S6) NSCs, respectively ( Figure 4Q ). Only 14% of the differentially expressed genes are common in these cell populations while the rest are differentially expressed in only one of the cell types ( Figure 4R ). Similarly, ngfra knockdown reduced the number of proliferating NSCs where NFkB signaling is active ( Figure 4S-T3) .
These results indicate that neuron-glia interaction through BDNF regulates NSC proliferation and neurogenesis through NGFRA/NFkB signaling ( Figure 5 ).
To explore the evolutionary conservation of our findings in healthy and Alzheimer's disease conditions, we determined the expression of BDNF, NTRK2 and p75/NTR (NGFRA ortholog in mouse) in wild type mouse and APP/PS1dE9 AD model ( Figures S5-7) . Compared to 12 month-old control mouse brains, agematched APP/PS1dE9 mouse displayed reduced SOX2 and increased GFAP ( Figures S5-7 ) that is indicative of reduced neurogenic ability and increased gliosis. We found that in mouse cortex and dentate gyrus (DG), BDNF is mainly expressed by non-glial cells ( Figure S5C -D'; Figure S6A -F), which is supported by the previous studies (Habib et al., 2016; Tabula Muris et al., 2018) and this pattern is not altered in AD brains ( Figure S5E NTRK2 is expressed in the cortex and DG, again mainly in non-glial cells but few GFAP-positive astrocytes were NTRK2-positive in both the wild type and AD mouse brains with no clear change in the expression pattern between healthy and diseased brains ( Figure S5G -J'). Overall, NTRK2 is expressed mainly by neurons, but also few astrocytes and microglia (FigureS6M-P). We found that p75/NTR is mainly expressed in neurons in the cortex and the DG, but NSC niche in the DG (subgranular zone, SGZ) does not express p75/NTR ( Figure S5K -N'; Figure S7 ). In both wild type and APP/PS1dE9 mouse, we could detect BDNF, NTRK2 and p75 expression; however, increased number of GFAP-positive astrocytes AD brains did not correlate with the expression of these proteins, suggesting that BDNF signaling might not regulate NSC proliferation in mouse brains.
To test this hypothesis, we investigated the effect of BDNF in wild-type and AD mouse brains by injecting BDNF into the mouse brains (Figure S5O-X; Fig S8) . BDNF injection was performed in one hemisphere of the mouse brain, whereas the other hemisphere was used as a control with PBS injection. We found that BDNF injection increased the overall proliferation levels in the brain as compared to PBS-injected hemispheres in both wild type and APP/PS1dE9 brains ( Figure S5O-V2 ). In addition we also checked the cell types that increase their proliferation levels.
To identify the BDNF-responsive proliferating cells, we performed co-staining with astrocyte marker GFAP and found that Ki67+ cells are GFAP negative, suggesting that BDNF responsive proliferating cells are not astrocytes ( Figure  S5O -R2; Figure S5W ; Figure S8A -C), Next, we performed Ki67 co-staining with microglial marker Iba1 and found that almost all Ki67-positive cells are Iba1positive, suggesting that BDNF induces microglial proliferation resulting in microgliosis but not NSC proliferation ( Figure S5S -V2; Figure S5X ; Figure S8D -F). Consistent with this hypothesis, we also found that SOX2-positive cells did not alter their proliferation levels after BDNF (data not shown), suggesting that BDNF does not alter NSC proliferation in mouse brains in healthy and AD conditions. This finding is consistent with the previous reports (Choi et al., 2018; Galvao et al., 2008; Reumers et al., 2008) . Additionally, due to the lack of p75NTR expression in NSCs present in SGZ of the mouse hippocampus, BDNF/p75NTR signaling, which enhances proliferative output of NSCs and neurogenesis in zebrafish brain, is not an active signaling mechanism in mouse brains. With these results, we propose that zebrafish utilizes special circuit mechanism that uses serotonin-BDNF signaling to enhance the NSC plasticity and to induce neurogenesis through neuronal intermediates; however, BDNF signaling is not regulating NSC plasticity and neurogenesis in mammalian brains while its effect is mainly on the neuronal survival and regulation of immune reaction (Chan et al., 2008; Galvao et al., 2008; Hamanoue et al., 1999; Huang and Reichardt, 2003; Takach et al., 2015; Yeiser et al., 2004) .
Discussion
Our results identify a previously uncharacterized regulatory circuit mechanism that involves neuronal intermediates for NSC plasticity of zebrafish brain in Alzheimer's disease (AD) conditions. This mechanism involves the suppressive effect of Serotonin on periventricular neurons that express bdnf, which directly regulates a subset of NSCs expressing BDNF receptor ngfra. Amyloid-induced Interleukin-4 suppresses the initial serotonergic output and therefore potentiates the bdnf expression and stem cell proliferation. We propose that induced expression of IL4 generates a disease-associated NSC niche environment that is supportive of NSC proliferation.
Serotonin affects neurogenesis, stem cell proliferation and normal functioning of neural circuitry; however, its effects on NSCs and neurogenesis are controversial (Alenina and Klempin, 2015) . In zebrafish, Serotonin positively affects NSC proliferation in midbrain but not the hypothalamus (Perez et al., 2013) , and promotes spinal motor neuron regeneration (Barreiro-Iglesias et al., 2015) . Although depletion of serotonin reduces adult neurogenic outcome in rats (Brezun and Daszuta, 1999) , elevated levels of serotonin in serotonin transporter (SERT) deficient mice did not affect NSC proliferation and neurogenesis (Bengel et al., 1998; Schmitt et al., 2007) . In mesencephalic and hippocampal progenitors of mouse brain, inhibition of serotonin receptors or knocking out serotonin-producing enzymes to generate hypo-serotonergic phenotypes had positive effects on neurogenesis (Diaz et al., 2013; Klempin et al., 2013; Parga et al., 2007; Sachs et al., 2013) ascertaining a negative role for serotonin on NSC plasticity. These findings indicate that the effects of serotonin on NSCs are context-dependent and may run through intermediary secondary signaling mechanisms, which supports our findings. Additionally, in majority of the studies, the specific receptors for serotonin were not investigated in NSCs; therefore our study provides a detailed delineation of the signaling cascades that link serotonergic input to the regulation of stem cell proliferation via intermediates, in our study by BDNF.
The interaction between serotonin and BDNF is partially understood. In stressrelated disorders depletion of serotonin reduces brain BDNF levels (Chen et al., 2007; Yoshida et al., 2012; Zhou et al., 2008) . On the contrary, hypo-serotonergic mouse (Tph2-/-or Pet1-/-) showed increased BDNF levels in hippocampus and prefrontal cortex (Diaz et al., 2013; Klempin et al., 2013; Kronenberg et al., 2016; Sachs et al., 2013) and humans with serotonin transporter deficiency (hyperserotonin) reduced the availability of BDNF (Molteni et al., 2010) , which enhances NSCs proliferation and neurogenesis (Arsenijevic and Weiss, 1998; Numakawa et al., 2017) . Our findings support the negative role of serotonin on BDNF signaling and NSC plasticity.
The effects of BDNF in AD are mainly on neuronal survival rather than neurogenesis or NSC plasticity. Although BDNF expression correlates with increased neuronal survival (Lee et al., 2002; Quesseveur et al., 2013; Waterhouse et al., 2012) , and may have positive impact on increased net hippocampal neurogenesis and better cognitive functioning (Rossi et al., 2006; Wrann et al., 2013) , several studies showed that these effects are not directly related to enhanced neurogenesis (Galvao et al., 2008; Reumers et al., 2008) . In fact, in a recent study, in 5X-FAD AD model of mice, increasing adult neurogenesis and simultaneous BDNF treatment increases cognitive output yet adult neurogenesis or BDNF alone are not sufficient to do so (Choi et al., 2018) , suggesting that a BDNF-dependent neuronal survival cascade is required to counteract the symptoms of AD after an independent stimulation of neurogenesis. In zebrafish, in contrast to mammals, BDNF directly regulates NSC plasticity and neurogenesis. Our results in APP/PS1dE9 mice also supported the findings in mice (Choi et al., 2018) and indicate that zebrafish has an intrinsic and natural ability to kick-start NSC proliferation and neurogenesis, which could teach us how to modulate mammalian brains to initiate "regeneration" of lost neurons in AD. (Leibrock et al., 1989) and its main receptor is TrkB/Ntrk2, which is predominantly expressed in neurons (Klein et al., 1991) in the cortex and DG as well as in few astrocytes and microglia as determined by single-cell sequencing (Habib et al., 2016; Tabula Muris et al., 2018) . BDNF also has binding affinity towards p75 receptor, which is primarily expressed by neurons in mammals (Habib et al., 2016; Tabula Muris et al., 2018 ). Yet, in zebrafish, ngfra was predominantly expressed in NSCs and were responsible for NSC plasticity. Zebrafish glial cells responded to BDNF via ngfra receptor, and activated proliferation and neurogenesis; whereas, mouse glial cells responded to BDNF by reactive astrogliosis and microgliosis. Therefore, our results also propose that the BDNF activity could be specialized to distinct receptor signaling pathways in vertebrate brains. For instance, BDNF-NGFRA signaling could be a factor underlying the regenerative and plastic nature of the NSCs in regenerating organisms such as zebrafish but not in non-regenerating organisms like mammals, where BDNF mostly acts through TrkB/Ntrk2 signaling. Further studies of this regulatory mechanism in other regenerating organisms would be instrumental in testing our hypothesis. Furthermore, inducing expression of ngfra in stem cell populations in mammalian brains could be a potential way to impose neurogenic plasticity to astrocytes in AD conditions. We found that IL4 suppresses the serotonin production in neurons that do not express il4r, suggesting that IL4 regulates serotonin availability indirectly. Indeed, pro-inflammatory cytokines such as IL-1β, TNFα, IFNα and IFNγ can increase 5-HT levels and the expression of 5-HT transporter SERT, which positively correlates with 5-HT levels in the brain (Baganz and Blakely, 2013; Linthorst et al., 1996; Masson and Hamon, 2009; Masson et al., 1999; Ramamoorthy et al., 1995; Shintani et al., 1993) . Theoretically, anti inflammatory factors would be expected to reduce 5-HT levels in the brain due to their role in suppression of pro-inflammatory factor expression. Indeed, IL4 reduces the 5-HT or SERT levels (Mossner et al., 2001; Pannell et al., 2014; Park et al., 2015; Wachholz et al., 2017) , supporting our findings. Therefore, in adult zebrafish brain, AD conditions elicit an inflammatory regulation by IL4 on serotonin, which translates into a neurotransmitter response in a specific neuronal subtype that directly regulates a subpopulation of NSCs.
BDNF expression is abundant in mammalian brains
Finally, we identified two functionally distinct populations of NSCs that are both responsive to IL4 but through different receptor signaling (IL4R/STAT6 and BDNF/NGFRA) and through distinct gene regulation (Figure3X,Y) . This finding suggests that NSC heterogeneity is an important determinant of how a certain type of neuropathology and a particular signaling pathway would affect certain subtypes of cells differentially (in AD regulation of proliferation by IL4 in two distinct branches of regulation (Figure5)). This understanding would be instrumental in designing targeted therapy options for AD in humans and may lead to more detailed analyses of NSC subtypes in experimental mammalian models of AD. Additionally, the role of Interleukin-4 and Serotonin in regulating diverse signaling mechanisms in NSCs opens up interesting research avenues as to whether modulation of neuroinflammatory milieu in mammalian brains would kick-start a "regeneration" response by mobilizing the endogenous reservoir of NSCs, which is a controversial subject (Arellano et al., 2018; Cipriani et al., 2018; Rodriguez and Verkhratsky, 2011; Sorrells et al., 2018; Tincer et al., 2016; Waldau and Shetty, 2008; Ziabreva et al., 2006) . We propose that zebrafish can be used to address neurogenesis-related questions in disease conditions and could serve as a useful experimental model for investigating the molecular mechanisms of neural stem cell plasticity. 
Experimental Procedures

Animal Experiments
Ethics statement: Animal experiments were carried out in accordance with the relevant permits from the Landesdirektion Sachsen, Germany (TVV-52/2015 and TVV-87/2016) .
Animal Handling and Husbandry:
For zebrafish studies, 6-8 months old WT-AB strain, Tg(her4.1:GFP) and Tg(NFkB:GFP) fish of both genders were used. For each set of experiments, same clutch of fish were randomly distributed for different experimental groups. Fish were maintained at 14 hour light / 10 hour dark cycle at constant 28 °C tanks. All animal experimentation was performed according to the official guidelines. For mouse studies, APP/PS1 mice was kept and bred according to established protocols. 12-months-old transgenic mice and WT littermates (males only) were used for the experiments. These mice were maintained following the institutional guidelines in standard animal housing conditions.
Peptide synthesis, cerebroventricular microinjection in adult zebrafish
Amyloid-β42 (Aβ42) synthesis was performed as described . Cerebroventricular microinjection in adult zebrafish brain were performed as previously described (Bhattarai et al., 2017a; Bhattarai et al., 2016; Bhattarai et al., 2017b) . PBS (1μl), Aβ42 (1 μl, 20 μM), IL4 (1 μl, 10 μg/ml), BDNF (1 μl, 100ng/ml), 5-HT (1 μl, 100 μM), ngfra morpholino (1μl, 10uM) were injected. See Table S1 for further information.
BrdU treatment
Experimental zebrafish were immersed in freshly prepared 10 mM BrdU (Sigma-Aldrich) solution in E3 for 8 hours per day at 2 and 3 days post-injection (dpi). Fish were sacrificed at 14 dpi, and heads were subjected to histological preparations.
Zebrafish tissue preparation, immunohistochemistry and in situ hybridization
Zebrafish tissue preparations, cryosectioning, mRNA probe synthesis and stainings were performed as previously described Kizil et al., 2012a; Kizil et al., 2012b) . See Table S1 for further information on reagents.
BDNF Injection into adult mouse brain
For mouse experiment, 100 ng of BDNF (1 μl, 100μg/ml) was injected into one hemisphere of the adult mouse brain, and the other hemisphere was injected with 1 µl PBS as a control. The injection procedure was carried out according to previously established protocol (Artegiani et al., 2011) . The mouse was placed in an induction chamber and anesthetized using a mix of oxygen and isoflurane flow. After the animal was recumbent, the gas flow directed to the nosecone of the stereotaxic frame. The mouse was then rapidly positioned on the nosecone to have constant supply of isoflurane and oxygen. The ear bars were fixed to immobilize the head. An analgesic was subcutaneously injected prior to surgery to minimize any possible pain after the recovery from anesthesia. During the entire surgery animal was placed on a pre-warmed heat-pad to prevent hypothermia. To prevent dehydration of cornea and further blinding of mouse, eyes wer covered with a protective ointment. All tools used during the surgery were sterilized using ethanol and/or Microzide. Using bregma as a reference point, the coordinates for the injections into the Dentate Gyrus were identified on both sides of the brain and holes were carefully drilled in the skull. The capillary was then slowly inserted until 1900 um of depth from skull level and 1 µl of BDNF (100μg/ml) was injected at 200 nl/min speed. After injection, the capillary was kept inside for 5 minutes to prevent backsplash and then slowly retracted. The same procedure was performed on the other hemisphere to inject 1 µl of PBS. The ear bars were then released, the skin was wetted with PBS to regain the elasticity and stitched. The wound was then treated with a disinfecting solution (Povidone). Mouse was placed in an individual cage under a red light with water and pre-soaked food (to make it easier for animal to bite after the surgery). Another injection of analgesic was performed 24 hours post-surgery. Mouse were sacrificed at 48 hours after injection and subjected for brain collection and further processing.
Mouse tissue preparations and stainings
For brain collection the adult mice were anesthetized with an intraperitoneal injection of a mixture of Ketamine and Xylazine (0,25 mL per 25g of body weight) and then intracardiacally perfused with NaCl 0.9% followed by cold freshly prepared 4% PFA (in phosphate buffer, pH 7.4). After perfusion brains were harvested and fixed with 4% PFA for 24 hours at 4°C and then washed 3 times with PBS. For cryopreservation of tissue fixed brais were further incubated overnight in 30% Sucrose solution in PBS at 4°C. Free-floating sections of 40µm thickness were prepared using microtome (Leica SM2010R) and were collected in 6 consecutive series in a Cryopreservation Solution (CPS) in a 24-well plate. Sections were then stored at -20 °C for further experiments. Prior to immunohistochemistry the free-floating sections were washed in PBS 3 times, blocked in 10% Donkey or Goat Serum with 0.2% TritonX for 1 hour at room temperature and incubated overnight at 4 °C with the desired primary antibody of defined dilution in 3% Donkey or Goat Serum with 0.2% TritonX. Sections were washed for 3 times within 1 hour and incubated for another 4 hours at room temperature with the correct secondary antibody coupled to a desired fluorophore. After short wash samples are then incubated in DAPI diluted in PBS (1:5000) for 10 minutes. Another 3 washing steps were done and samples were then mounted on the charged glass slides (Thermo Fisher, SuperFrostTM). After mounting slides are left to dry and covered with a coverslip using Aqua Mount. See Table S1 for further information on reagents.
Imaging and quantifications
Images were acquired using ZEN software on a Zeiss fluorescent microscope with ApoTome or Zeiss AxioImager Z1 and analyzed using ZEN or ImageJ software. Quantifications were performed in double blind fashion. Stereological quantifications in zebrafish were performed by manual counting on one third of the whole sections from the Telencephalon (caudal olfactory bulb until the rostral optic tectum). Quantifications for serotonergic densities were performed using a 3D object counter module of ImageJ software. At least 4 animals with minimum 8 histological sections per animal were used for stereological analyses in all in situ hybridization and immunohistochemical stainings unless otherwise stated.
Statistical analyses
All experiments were performed at least with two replicates. For comparison of two particular experimental groups, a two-tailed student's t-test was performed. For comparison of multiple experimental groups, one-way ANOVA with Tukey's post-test were performed. Statistical analyses were performed using Excel software and GraphPad Prism. p-values less than 0.05 were considered significant. Error bars in Fig.s indicate the standard error of means. Significance indicated by * (p < 0.05), * * (p < 0.01), and * * * (p < 0.001), n.s. (not significant, p > 0.05). No sample set was excluded from the analyses unless the histological sections were damaged severely during the acquisition of the sections (constitutes less than 4% of all sections analyzed).
Cell dissociation, sorting, whole transcriptome and single-cell sequencing
The telencephalon was dissected using ice-cold PBS and Neural Tissue Dissociation Kit (Miltenyi) as described previously . Deep sequencing for whole transcriptome was performed as described Papadimitriou et al., 2018) . For single cell sequencing, isolated cells were passed through a 40-µm cell strainer. Viability indicator (Propidium iodide) and GFP were used to sort live cells. Cell suspension was loaded into the 10X Chromium system (Zheng et al., 2016) . 10X libraries were prepared as per the manufacturer's instructions. The raw sequencing data was processed by the cell ranger software provided by the 10X genomics with the default options. The reads were aligned to zebrafish reference transcriptome (ENSEMBL Zv10, release 91). Analyses matrices were used as input for downstream data analysis by Seurat (Butler et al., 2018) . Analyses were performed as described (Cosacak et al., 2019) .
Data Analysis by Seurat
Read10X function was used for generated matrices. Cells that contain more than 1000 UMI and more than 200 unique genes were taken into consideration. The data was normalized by using "LogNormalize" method, and was scaled with "scale.factor = 1e4". Variable genes were detected with FindVariableGenes using the default options. The top1000 most variable genes from each sample were merged, and CCA analysis was performed on the variable genes. A merged Seurat object was created with RunMultiCCA function, using num.ccs = 50. The canonical correlation strength was calculated using num.dims = 1:20. The reduction was performed by reduction.type = "pca", dims.use = 1:20, then the data subset by using "var.ratio.pca" and "accept.low = 0.5". The samples were aligned using dims.align = 1:20. The cell clusters were found using aligned CCA and 1:20 dims, with higher resolution 2.5. Clusters were shown on 2D using t-SNE function. We used the genes from literature (Dataset S4) and markers found by Seurat functions to define our cell types. For that, we generated FeaturePlot for all marker genes and checked the expression and specificity of the marker to define cell types.
Pathway analyses and interaction mapping by machine learning
We used all marker genes with False Detection Rate < 0.1 for Gene Ontology analysis and KEGG pathway analysis using GOStats (1.7.4) (Falcon and Gentleman, 2007) and GSEABase (1.40.1), p-value < 0.05 as thresholds. To determine the differentially expressed genes (DEGs), we used FindMarkers function using cell cluster that have at least 3 cells from all samples. Then, we used the p-value <0.05 for significantly expressed genes. These genes were used for GO and pathway analysis using the scripts that are available on https://kizillab.org/resources.
Cell types in Serotonin single-cell sequencing dataset were identified by using machine learning algorithms. Top-1000 most variable genes for three samples (PBS, AB42 and IL4 as previously described (Cosacak et al., 2019) ) were determined. These genes were used to train RandomForest algorithm to learn cell types from existing samples. The cells in 5-HT treated samples were predicted accordingly. We identified marker genes, differentially expressed genes (DEGs), interaction maps as described before (Cosacak et al., 2019) .
To identify DEGs in specific cell types, we added new "idents" to the R-object as the following: Treatment (PBS, AB42, IL4 or 5HT)_Main Cell Types (Im, PC, NN, OPC/OD1 or OPC/OD_2)_receptor name. For instance; AB42_PC_htr1a was compared to PBS_PC_htr1a cells. The DEGs in each of these cells were identified after each treatment using FindMarkers function in Seurat. p-value < 0.05 and |avg_logFC| >= 0.25 were used for significantly expressed genes, p-value < 0.05 was used for over-represented GO terms and KEGG pathways as described (Cosacak et al., 2019) .
Data availability
GEO Accession numbers for sequencing datasets are as follows: single cell sequencing: GSM3334110 (control), GSM3333461 (Amyloid-beta42), GSM3333764 (Interleukin-4) (as described in (Cosacak et al., 2019) ) and GSM3334111 (5-HT/Serotonin); whole transcriptome deep sequencing dataset: GSE124162. All R-Codes are available on kizillab.org/resources. 
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